Cost, Insurance Coverage, and Generic Alternatives
These updates highlight DRAP’s efforts to ensure quality and compliance in Pakistan’s healthcare system. 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No. BXNZ2488), falsely claiming to be manufactured by Bayer Pharma AG, Germany. Testing by the Central Drugs Laboratory confirmed that this mail order levitra online batch is falsified and unregistered.
| Condition | Description | Recommended use |
|---|---|---|
| Erectile Dysfunction | Difficulty in achieving or maintaining an erection | As prescribed by a doctor |
| Pulmonary Arterial Hypertension | Off-label use in some cases | Not approved without supervision |
| Menopause-related Sexual Dysfunction | Experimental treatment | Not approved officially |
Its safety, quality, and efficacy have not been evaluated or approved. Use of such medicines can result in treatment failure, adverse reactions, or serious health risks.
- Levitra 20 mg Bayer is designed for adult men with ED.
- It should be used with caution in patients with liver or kidney issues.
- The medication may cause visual disturbances in some users.
- Levitra 20 mg Bayer does not protect against sexually transmitted infections.
- Measuring your response can help determine proper dosage.
- Avoid taking Levitra if you have any known allergies to it.
- Some users report improved confidence after taking Levitra.
- The drug can sometimes cause a mild decrease in blood pressure.
- You should not crush or chew the tablets; swallow whole.
- Use medication only as prescribed by a healthcare professional.
- Levitra 20 mg Bayer is part of a broader class of ED treatments.
Regulatory Action: DRAP has instructed its field and provincial authorities to seize this product. Pharmacies, distributors, and healthcare institutions are advised to check their inventories immediately and report any presence of this batch to the authorities. For Healthcare Professionals: Stay vigilant for falsified or unregistered medicines.
| Country | Legal Status | Prescription Requirement |
|---|---|---|
| USA | Prescription drug | Yes |
| UK | Prescription only medicine | Yes |
| Australia | Prescription-only medicine | Yes |
| Canada | Prescription drug | Yes |
Report any suspected cases or adverse reactions to DRAP’s pharmacovigilance system. Always purchase medicines from licensed pharmacies and verify their registration details. Seek medical attention if you experience any unusual effects. Ensuring medicine safety is a shared responsibility. Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No.
- Levitra 20 mg Bayer is a popular choice for erectile health issues.
- It should not be used in combination with certain medications like alpha-blockers.
- Men with heart conditions should consult a doctor prior to use.
- The pill’s onset can vary between individuals, typically about 30 minutes.
- It is not an aphrodisiac, and sexual arousal is necessary for effectiveness.
- Levitra 20 mg Bayer is not intended for recreational use.
- The medication’s effectiveness can be influenced by age and health status.
- Overdose symptoms may include priapism, a painful erection lasting several hours.
- Pregnant or breastfeeding women should avoid using Levitra.
- Proper hydration can help reduce some side effects.
- Keep out of reach of children and protected from moisture.
Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG).
- Levitra 20 mg Bayer is a prescription medication for erectile dysfunction.
- It helps increase blood flow to facilitate an erection.
- The medication is taken about 30 minutes before sexual activity.
- Levitra 20 mg Bayer’s effects can last up to 4-5 hours.
- It belongs to a class called PDE5 inhibitors.
- Possible side effects include headaches, dizziness, and flushing.
- Do not use Levitra if you take nitrates or heart medications.
- Consult a healthcare provider before starting this medication.
- Levitra 20 mg Bayer should be stored in a cool, dry place.
- Do not exceed the prescribed dose to avoid adverse effects.
- Alcohol consumption can diminish the effectiveness of Levitra.
𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗵𝘄𝗮𝘆𝘀 🔸There are two main types of listed medicines: 🔸AUST L medicines: These are low-risk and do not undergo pre-market efficacy review. 🔸AUST L(A) medicines: Also low-risk, but they require TGA assessment of efficacy evidence and may carry a “TGA assessed” claim.
- Levitra 20 mg Bayer is supplied in blister packs for convenience.
- It is essential to adhere to prescribed timing and dosage.
- OTC availability varies by country; prescription is generally required.
- Patients should report any unusual eye or vision changes promptly.
- Levitra’s effects can be influenced by other health conditions.
- Men should avoid unnecessary driving or dangerous activities after use.
- The medication is part of a balanced approach to sexual health.
- Levitra may require dose adjustments based on individual response.
- Avoid using other ED medications simultaneously without medical advice.
- Nutritional supplements claiming to enhance ED are not regulated.
- Proper storage and handling ensure medication effectiveness.
𝗦𝗽𝗼𝗻𝘀𝗼𝗿 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 Sponsors must certify that their medicine: 🔸Is eligible for listing under the Act.
Secondary Outcome
But insurance plans may not cover Levitra or generic vardenafil that you purchase from a third-party website, even if the medication was prescribed to you by a licensed physician. Levitra is not covered under Part D of Medicare, an optional Medicare benefit that can help cover the costs of eligible prescription medications. Some generic forms of vardenafil are covered under Part D. Generic versions of other popular ED medications like Viagra are also covered to some extent under Part D. Levitra is just one of several PDE5 inhibitors you can try to treat ED symptoms.
Diagnosis and treatment of erectile dysfunction
Here’s a breakdown of how Levitra compares to several other popular alternatives, including the dose they come in and how long you can expect them to work once you take them. Note: When used for ED, these medications should only be taken once per day. Levitra can seem expensive, but you have plenty of options to help reduce the price you pay at the pharmacy by choosing generic alternatives, using manufacturer or retail coupons, or trying other ED medications. Talk with your doctor before you start taking Levitra or any generic form of vardenafil. You may experience side effects or complications if you take the wrong dosage or take it at the wrong times. 🔸Contains only permissible ingredients and meets all ingredient-related requirements. 🔸Complies with advertising, manufacturing, and GMP standards. 🔸Has written agreements with all nominated manufacturers. 🔸Includes only approved indications and claims, with supporting evidence. 🔸Does not contain prohibited substances or imports. 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 Sponsors use the TGA Business Services portal to: 🔸Enter product details. 🔸Receive an AUST L or AUST L(A) number and certificate.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Levitra Generic | 60mg | 360 + 10 Pills | 906.69€ 863.51€ | |
| Levitra Generic | 10mg | 60 + 6 Pills | 112.98€ 107.60€ | |
| Levitra Generic | 20mg | 10 Pills | 31.49€ 29.99€ | |
| Levitra Soft Tabs | 20mg | 10 Pills | 52.27€ 49.78€ | |
| Levitra Generic | 10mg | 30 + 4 Pills | 62.39€ 59.42€ | |
| Levitra Original | 20mg | 14 + 2 Pills | 102.27€ 97.40€ | |
| Levitra Generic | 60mg | 180 + 10 Pills | 501.43€ 477.55€ | |
| Levitra Soft Tabs | 20mg | 120 + 8 Pills | 288.52€ 274.78€ | |
| Levitra Professional | 20mg | 20 Pills | 101.00€ 96.19€ | |
| Levitra Generic | 40mg | 60 + 4 Pills | 162.37€ 154.64€ | |
| Levitra Original | 20mg | 12 Pills | 81.99€ 78.09€ | |
| Levitra Original | 20mg | 34 + 2 Pills | 188.51€ 179.53€ | |
| Levitra Generic | 10mg | 10 Pills | 28.93€ 27.55€ |
𝗣𝗼𝘀𝘁-𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Once listed, sponsors must: 🔸Maintain pharmacovigilance records and report adverse events.
Levitra’s Role in Combating Erectile Dysfunction (ED)
Generic name: VARDENAFIL HYDROCHLORIDE 5mg Dosage form: tablet, film coated Drug class: Impotence medications For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally, as needed, approximately 60 minutes before sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day. Sexual stimulation is required for a response to treatment. Geriatrics: A starting dose of 5 mg LEVITRA should be considered in patients ≥ 65 years of age.
The impact of a shortage of Medicine in Pakistan: Causes and solutions
Hepatic Impairment: For patients with moderate hepatic impairment (Child-Pugh B), a starting dose of 5 mg LEVITRA is recommended. The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. Do not use LEVITRA in patients with severe hepatic impairment (Child-Pugh C). Renal Impairment: Do not use LEVITRA in patients on renal dialysis. Nitrates: Concomitant use with nitrates and nitric oxide donors in any form is contraindicated. 🔸Comply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba).
| Side Effect | Frequency | Severity | Advice |
|---|---|---|---|
| Headache | Common | Mild | Take analgesics if needed |
| Flushing | Common | Mild | Stay hydrated |
| Nasal congestion | Less common | Mild | Use decongestants if necessary |
| Dizziness | Less common | Mild | Sit or lie down immediately |
🔸Notify the TGA of overseas recalls or safety issues. 𝗠𝗮𝗸𝗶𝗻𝗴 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 Sponsors may request changes to their ARTG entry to: 🔸Correct errors.
Primary Outcome
2024 DRAP Updates: What You Need to Know This year, the Drug Regulatory Authority of Pakistan (DRAP) has made some important updates to improve the safety and quality of healthcare products in Pakistan. Here’s a quick breakdown of what’s new: 1. Streamlined Product Enlistment DRAP has made it easier for companies to get herbal, homeopathic, and nutraceutical products enlisted by releasing provisional FIFO lists for applications submitted in 2024.2. Stronger Pharmacovigilance The third edition of the National Pharmacovigilance Guidelines has been published, bringing the system in line with WHO recommendations to ensure safer medicines.3. Easier Reporting for Adverse Drug Reactions DRAP extended its E-Reporting System, making it simpler for companies to report safety concerns and help improve drug monitoring.4.
A comprehensive review of erectile dysfunction in men with diabetes
Updated Fee Structure To improve services, DRAP revised the fees for 132 regulatory processes, aligning them with current needs.5. Support for Biological Product Trials A new draft guidance document provides a clear roadmap for conducting clinical trials of locally manufactured biological products.6. Good Clinical Practice (GCP) Inspections DRAP is ramping up inspections to ensure clinical trials meet international ethical and scientific standards.7. Quality Alerts The authority has issued warnings about contamination risks in certain products, like ethylene glycol, to protect public health.8. Latest DRAP Newsletter The latest quarterly newsletter is packed with updates, including the extension of the e-reporting system and other initiatives to improve healthcare safety. 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country.
How should I use Levitra?
Guanylate Cyclase (GC) Stimulators, such as riociguat: Concomitant use is contraindicated. CYP3A4 Inhibitors: The dosage of LEVITRA may require adjustment in patients receiving potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, atazanavir, and clarithromycin as well as in other patients receiving moderate CYP3A4 inhibitors such as erythromycin. For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period. For indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period.
Pharmacotherapy for erectile dysfunction
Alpha-Blockers: In those patients who are stable on alpha-blocker therapy, phosphodiesterase type 5 (PDE5) inhibitors should be initiated at the lowest recommended starting dose. Concomitant treatment should be initiated only if the patient is stable on his alpha-blocker therapy. Stepwise increase in alpha-blocker dose may be associated with further lowering of blood pressure in patients taking a phosphodiesterase (PDE5) inhibitor including vardenafil. In those patients who are stable on alpha-blocker therapy, LEVITRA should be initiated at a dose of 5 mg (2.5 mg when used concomitantly with certain CYP3A4 inhibitors). A time interval between dosing should be considered when Levitra is prescribed concomitantly with alpha-blocker therapy.
